BioNTech
Alexander Birke is a Senior Scientist in Late-Stage Formulation Process Development at BioNTech SE since November 2020, previously serving as a Scientist in Process Development for Large-Scale RNA Lipoplex Manufacturing. Prior to this, Alexander held a Postdoctoral position at Sanofi from October 2017 to September 2019, focusing on the development of a targeted, polymer-based nanoparticulate drug delivery system and leading a small team. Early experience includes a role as a Molecular Biology Laboratory Temp at Bioscientia Institut für Medizinische Diagnostik GmbH, where influenza A/H1N1 quantification was conducted during an epidemic. Alexander earned a Dr. rer. nat. in Biomedical Chemistry from Johannes Gutenberg University Mainz in 2017 and completed the Abitur at Sebastian-Münster Gymnasium in 2007.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.